Key NS - Search Results

1

The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells.

Whelihan MF, Mooberry MJ, Zachary V, Bradford RL, Ataga KI, Mann KG, Key NS. Whelihan MF, et al. Among authors: key ns. J Thromb Haemost. 2013 Dec;11(12):2187-9. doi: 10.1111/jth.12423. J Thromb Haemost. 2013. PMID: 24119168 Free PMC article. No abstract available.

2

Red blood cells and thrombin generation in sickle cell disease.

Whelihan MF, Lim MY, Key NS. Whelihan MF, et al. Among authors: key ns. Thromb Res. 2014 May;133 Suppl 1(0 1):S52-3. doi: 10.1016/j.thromres.2014.03.021. Thromb Res. 2014. PMID: 24759144 Free PMC article.

3

Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.

Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, Cai J, Monroe DM, Ataga KI, Mann KG, Key NS. Whelihan MF, et al. Among authors: key ns. J Thromb Haemost. 2016 Oct;14(10):1941-1952. doi: 10.1111/jth.13416. Epub 2016 Aug 31. J Thromb Haemost. 2016. PMID: 27430959 Free article.

4

Hemostatic abnormalities in sickle cell disease.

Lim MY, Ataga KI, Key NS. Lim MY, et al. Among authors: key ns. Curr Opin Hematol. 2013 Sep;20(5):472-7. doi: 10.1097/MOH.0b013e328363442f. Curr Opin Hematol. 2013. PMID: 23817169 Review.

5

Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.

Mooberry MJ, Bradford R, Hobl EL, Lin FC, Jilma B, Key NS. Mooberry MJ, et al. Among authors: key ns. J Thromb Haemost. 2016 May;14(5):1031-42. doi: 10.1111/jth.13285. Epub 2016 Apr 5. J Thromb Haemost. 2016. PMID: 26857798 Free PMC article.

6

Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Noubouossie D, Key NS, Ataga KI. Noubouossie D, et al. Among authors: key ns. Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24. Blood Rev. 2016. PMID: 26776344 Free PMC article. Review.

7

Hypercoagulability in sickle cell disease: new approaches to an old problem.

Ataga KI, Key NS. Ataga KI, et al. Among authors: key ns. Hematology Am Soc Hematol Educ Program. 2007:91-6. doi: 10.1182/asheducation-2007.1.91. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024615 Review.

8

Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, Bergmeier W, Mackman N. Geddings JE, et al. Among authors: key ns. J Thromb Haemost. 2016 Jan;14(1):153-66. doi: 10.1111/jth.13181. Epub 2015 Dec 11. J Thromb Haemost. 2016. PMID: 26516108 Free PMC article.

9

Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop.

Cointe S, Judicone C, Robert S, Mooberry MJ, Poncelet P, Wauben M, Nieuwland R, Key NS, Dignat-George F, Lacroix R. Cointe S, et al. Among authors: key ns. J Thromb Haemost. 2017 Jan;15(1):187-193. doi: 10.1111/jth.13514. Epub 2016 Nov 26. J Thromb Haemost. 2017. PMID: 27662257 Free PMC article.

10

Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.

Willemze R, Bradford RL, Mooberry MJ, Roubey RA, Key NS. Willemze R, et al. Among authors: key ns. Thromb Res. 2014 Feb;133(2):187-9. doi: 10.1016/j.thromres.2013.11.027. Epub 2013 Dec 1. Thromb Res. 2014. PMID: 24332063 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters